Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 1171 AL 1185

Rit subfamily small GTPases: regulators in neuronal differentiation and survival

Shi GX, Cai W, Andres DA.

Cell Signal. 2013 Oct;25(10):2060-8. doi: 10.1016/j.cellsig.2013.06.002. Epub 2013 Jun 11.

Lack of association between the LRRK2 A419V variant and Asian Parkinson's disease

Gopalai AA, Lim SY, Aziz ZA, Lim SK, Tan LP, Chong YB, Tan CT, Puvanarajah S, Viswanathan S, Kuppusamy R, Tan AH, Lim TT, Eow GB, Norlinah MI, Li HH, Zhao Y, Ahmad-Annuar A.

Ann Acad Med Singap. 2013 May;42(5):237-40.

[Series: clinical study from Japan and its reflections: a multicenter study on repetitive transcranial magnetic stimulation therapy for Parkinson disease]

Shirota Y, Ohtsu H, Hamada M, Enomoto H, Ugawa Y.

Nihon Naika Gakkai Zasshi. 2013 Apr 10;102(4):1010-6. doi: 10.2169/naika.102.1010.

Neuropharmacological review of the nootropic herb Bacopa monnieri

Aguiar S, Borowski T.

Rejuvenation Res. 2013 Aug;16(4):313-26. doi: 10.1089/rej.2013.1431.

The mini-mental Parkinson's (MMP) as a cognitive screening tool in people with Parkinson's disease

Caslake R, Summers F, McConachie D, Ferris C, Gordon J, Harris C, Caie L, Counsell C.

Curr Aging Sci. 2013 Dec;6(3):273-9. doi: 10.2174/18746098112059990030.

Measuring functional impact of cognitive impairment: validation of the Parkinson's disease cognitive functional rating scale

Kulisevsky J, Fernández de Bobadilla R, Pagonabarraga J, Martínez-Horta S, Campolongo A, García-Sánchez C, Pascual-Sedano B, Ribosa-Nogué R, Villa-Bonomo C.

Parkinsonism Relat Disord. 2013 Sep;19(9):812-7. doi: 10.1016/j.parkreldis.2013.05.007. Epub 2013 Jun 15.

Redox modification of proteins as essential mediators of CNS autophagy and mitophagy

Lizama-Manibusan B, McLaughlin B.

FEBS Lett. 2013 Aug 2;587(15):2291-8. doi: 10.1016/j.febslet.2013.06.007. Epub 2013 Jun 15.

Central factors explain muscle weakness in young fallers with Parkinson's disease

Moreno Catalá M, Woitalla D, Arampatzis A.

Neurorehabil Neural Repair. 2013 Oct;27(8):753-9. doi: 10.1177/1545968313491011. Epub 2013 Jun 17.

Neuroscience of exercise: from neurobiology mechanisms to mental health

Matta Mello Portugal E, Cevada T, Sobral Monteiro-Junior R, Teixeira Guimarães T, da Cruz Rubini E, Lattari E, Blois C, Camaz Deslandes A.

Neuropsychobiology. 2013;68(1):1-14. doi: 10.1159/000350946. Epub 2013 Jun 15.

A systematic review of studies on anatomical position of electrode contacts used for chronic subthalamic stimulation in Parkinson's disease

Caire F, Ranoux D, Guehl D, Burbaud P, Cuny E.

Acta Neurochir (Wien). 2013 Sep;155(9):1647-54; discussion 1654. doi: 10.1007/s00701-013-1782-1. Epub 2013 Jun 19.

Subthalamic nucleus deep brain stimulation does not improve visuo-motor impairment in Parkinson's disease

Israeli-Korn SD, Hocherman S, Hassin-Baer S, Cohen OS, Inzelberg R.

PLoS One. 2013 Jun 11;8(6):e65270. doi: 10.1371/journal.pone.0065270. Print 2013.

The histaminergic network in the brain: basic organization and role in disease

Panula P, Nuutinen S.

Nat Rev Neurosci. 2013 Jul;14(7):472-87. doi: 10.1038/nrn3526.

Unmasked superoparaseptal pathway conduction due to atrial fibrillation in a patient with left ventricular dysfunction. Rapid recovery after successful radiofrequency ablation

Prochnau D, Surber R, Kuehnert H, Figulla HR.

Herzschrittmacherther Elektrophysiol. 2013 Sep;24(3):191-3. doi: 10.1007/s00399-013-0274-6. Epub 2013 Jun 20.

Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations

Kometer M, Schmidt A, Jäncke L, Vollenweider FX.

J Neurosci. 2013 Jun 19;33(25):10544-51. doi: 10.1523/JNEUROSCI.3007-12.2013.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias